^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OvaME

    Company:
    GenoME Diagnostics
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    OvaME, is in development and validation stages. It measures the levels of patented DNA methylation markers in a blood sample, incorporating the high sensitivity of droplet digital PCR. The cutting-edge approach to biomarker identification in ovarian cancer means OvaME has the potential to detect changes in the very earliest stages of disease.
    Cancer:
    Ovarian Cancer
    Method:
    Cutting-edge droplet digital PCR